The current valuation score of Takeda Pharmaceutical Co Ltd is 8.63, ranking 74 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 40.75, which is 493.43% below the recent high of 241.82 and 75.16% above the recent low of 10.12.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.